Reset Map2 Results
Calle de Santiago Grisolia 2 Tres Cantos, Madrid, 28760 SpainVivia offers pharmacological profiling and CDx/biomarker discovery services in patient samples to provide key information for drug development. We partner with drug developers throughout every stage of drug research and development with our proprietary PharmaFlow Technology Platform, from target discovery to biomarker discovery and companion diagnostic in clinical trials. We are working with more than 20 pharmaceutical and biotechnology companies worlwide to enable precision medicine driven therapies. PharmaFlow PM is a precision medicine platform to personalize the treatment of patients suffering Hematological Malignances. PharmaFlow PM generates clinically predictive data: patients predicted sensitive in 1st line show 92% CR at induction and 75% OS at 3-years* Vivia enables early identification of drug resistant clones to unleash targeted molecular biomarker discovery programs, uncovering the molecular basis of resistance of your drug. Vivia offers unique, state of the art, native environment immune-oncology and microenvironment assays. PharmaFlow PM CDx can deliver over 90% compelete remisión (CR) on your drug’s clinical trial. 92% CR 92% 75% OS 75% * Results from observational clinical trial with Pethema in Spain in 123 AML patients treated with first line Cytarabine and Idarubicin. Publication ready for early issuance. Vivia offers to its partners proprietary Native Environment Assays in patient’s whole bone marrow, assessing the drug activity in the native tumor microenvironment: Assays include state of the art immune-oncology (IO drugs, CAR-T), and microenvironment assays (BCR inhibtiors) Key deliveries of PharmaFlow PM for your drug development: Direct impact in ROI over 90% CR in clinical trials as CDx Identification of early molecular biomarkers of efficacy/resistance Better understanding of MOA & interpatient variability of response Best combos to incrase market share & overcome resistance in clinical trials Market positioning vs. SOC and competitive drugs Vivia can also enable fast deployment of Investigator Sponsored Trials with its European KOL network, where PharmaFlow PM would be used as CDx.
2 Calle de Santiago Grisolía Tres Cantos, Comunidad de Madrid, 28760 SpainVivia offers pharmacological profiling and CDx/biomarker discovery services in patient samples to provide key information for drug development. We partner with drug developers throughout every stage of drug research and development with our proprietary PharmaFlow Technology Platform, from target discovery to biomarker discovery and companion diagnostic in clinical trials. We are working with more than 20 pharmaceutical and biotechnology companies worlwide to enable precision medicine driven therapies. PharmaFlow PM is a precision medicine platform to personalize the treatment of patients suffering Hematological Malignances. PharmaFlow PM generates clinically predictive data: patients predicted sensitive in 1st line show 92% CR at induction and 75% OS at 3-years* Vivia enables early identification of drug resistant clones to unleash targeted molecular biomarker discovery programs, uncovering the molecular basis of resistance of your drug. Vivia offers unique, state of the art, native environment immune-oncology and microenvironment assays. PharmaFlow PM CDx can deliver over 90% compelete remisión (CR) on your drug’s clinical trial. 92% CR 92% 75% OS 75% * Results from observational clinical trial with Pethema in Spain in 123 AML patients treated with first line Cytarabine and Idarubicin. Publication ready for early issuance. Vivia offers to its partners proprietary Native Environment Assays in patient’s whole bone marrow, assessing the drug activity in the native tumor microenvironment: Assays include state of the art immune-oncology (IO drugs, CAR-T), and microenvironment assays (BCR inhibtiors) Key deliveries of PharmaFlow PM for your drug development: Direct impact in ROI over 90% CR in clinical trials as CDx Identification of early molecular biomarkers of efficacy/resistance Better understanding of MOA & interpatient variability of response Best combos to incrase market share & overcome resistance in clinical trials Market positioning vs. SOC and competitive drugs Vivia can also enable fast deployment of Investigator Sponsored Trials with its European KOL network, where PharmaFlow PM would be used as CDx.
Site Information
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
What is Scientist.com?
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
How can I use Scientist.com?
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Why should I place my order through Scientist.com?
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
How do I get my organization listed on the map?
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Information about my organization is incorrect, how do I fix it?
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.